Metabolite Profiling of Colon Cancer
Author Information
Author(s): Carsten Denkert, Jan Budczies, Wilko Weichert, Gert Wohlgemuth, Martin Scholz, Tobias Kind, Silvia Niesporek, Aurelia Noske, Anna Buckendahl, Manfred Dietel, Oliver Fiehn
Primary Institution: Charité University Hospital
Hypothesis
Can metabolite profiling differentiate between normal colon tissue and colorectal cancer tissue?
Conclusion
Metabolic profiling can effectively distinguish between normal and cancerous colon tissue, revealing significant biochemical differences.
Supporting Evidence
- 206 metabolites were detected, with significant differences between cancer and normal tissues.
- 82 metabolites were significantly different at p < 0.01.
- Principal component analysis showed high potential for diagnostic value in metabolic profiles.
Takeaway
This study looked at samples from colon cancer and normal tissue to see how their chemicals differ, helping us understand cancer better.
Methodology
Gas chromatography-time of flight mass spectrometry (GC-TOF) was used to analyze paired samples of normal and cancerous colon tissue.
Potential Biases
Potential biases due to variations in individual patient metabolism and nutritional intake.
Limitations
Normalization of data may affect results, and the study's design does not allow for precise timing of tissue collection.
Participant Demographics
27 primary colon carcinomas and 18 normal mucosa samples, with 15 paired samples from the same patients.
Statistical Information
P-Value
p<0.00024
Statistical Significance
p<0.00024
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website